Viatris
General
Deals Digest: Momentum falls marginally this week; M&A volume also lacklustre
Private Equity (PE) and venture capital (VC) dealmaking activity this week saw a slight dip in terms of value, while ......
Healthcare
Kotak fund to part-finance Matrix Pharma's purchase of Viatris API business
Kotak Alternate Asset Managers Ltd, the alternative investment arm of Kotak Group, said Monday it will part-finance the acquisition of Viatris Inc's ......
General
Grapevine: CX Partners starts Veeda Clinical sale process; Ola CEO departs amid job cuts
CX Partners, a mid-market private equity firm, has started the process to divest its majority stake in Veeda Clinical Research, an ......
General
Grapevine: KKR mulls JB Pharma sale; Bharti eyes Del Monte JV exit
Private equity firm KKR & Co. is exploring options for a potential sale of its 53.8% controlling stake in Mumbai-based ......
Healthcare
Matrix Labs founder Nimmagadda Prasad's firm buys Viatris' India API business
Viatris Inc., the result of the merger between Mylan NV and Pfizer Inc.’s Upjohn unit in 2020, has sold two ......
Healthcare
Biocon Biologics appoints new MD, CEO
Biocon Biologics on Monday said it has appointed Shreehas Tambe as managing director and chief executive officer of the company. ......
Healthcare
Biocon concludes Viatris' $3 bn acquisition
Biosimilars manufacturing arm of Biocon Ltd, Biocon Biologics, on Tuesday announced completion of acquisition of Viatris' global biosimilars business for ......
Healthcare
Analysis: M&A deal value in healthcare and pharma hits record high in Jan-June
Merger and acquisitions (M&As) deal value in the healthcare and pharmaceutical space hit a record high in Jan-June, crossing the ......
Healthcare
India's Biocon in talks with Mylan to merge biosimilar businesses - Moneycontrol
Indian drugmaker Biocon Ltd is in talks with generic drugmaker Mylan for a merger of their biosimilar businesses, financial news ......